$RLX

RLX Technology (RLX) Q2 2026 Earnings Call Transcript

RLX Technology reported Q2 2026 net revenue of RMB 1,010.5 million, up 14.8% YoY, driven by international expansion and a 2025 acquisition. Gross margin expanded to 35.4% from 27.5% YoY. International sales contributed 70% of revenue. Non-GAAP income from operations rose 28.8% YoY to RMB 149.6 million. GAAP net income increased 1.6% YoY to RMB 222.0 million. Management highlighted growth in oral nicotine pouches and a 51% investment in a European distributor.

Original reporting
Published Aug 21, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 4:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RLX Technology (RLX) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$RLXNeutralMed
01

Why it matters

Earnings beat provides fresh data for valuation models; regulatory risk in China may affect near‑term sentiment.

02

Market read

First disclosure of Q2 earnings for RLX, offering actionable insight for traders.

03

What to watch

Potential upside from upcoming U.S. PMTA approvals and new Southeast Asia manufacturing hub.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

RLX Technology Inc. reported its Q2 2026 results, detailing revenue growth, margin expansion, and strategic investments.

Company-level read

Ticker impact

$RLXNeutralMedium confidence
Context

Q2 2026 earnings released with 14.8% revenue growth, margin expansion and a 51% investment in a European distributor.

Expected impact

Potential modest upside if investors focus on international growth; downside risk from China regulatory concerns.

Evidence & confidence

Strong top‑line and margin data are positive, but guidance for China is flat and regulatory headwinds remain.

Market effects

Highlights growth in the oral nicotine pouch market and international expansion for FMCG‑type consumer tech.

Positive signal for European distribution channels; cautious outlook for Mainland China.

Adds to broader narrative of regulatory scrutiny on tobacco‑related products worldwide.

Counterpoint

Investors may discount earnings strength due to flat China outlook and heightened regulatory risk.

Key entities

  • Kate Wang

    Chief Executive Officer of RLX Technology.

  • Sam Tsang

    Head of Capital Markets, provided commentary on growth and risks.

Related articles

$RLXMed

RLX Technology (RLX) Bets Big On Europe And Nicotine Pouches

RLX Technology (RLX) reported Q2 2026 revenue of RMB1.01B (+14.8% YoY), with international sales at 70% of revenue. Gross margin expanded to 35.4% due to supply chain and product mix improvements. The company acquired a 51% stake in a European distributor, aiming to build direct retail relationships. However, China revenue is expected to be flat for the year due to regulatory tightening. RLX is also investing in nicotine pouches and has RMB13.9B in capital resources.

$RLXMed

RLX Technology Inc. (RLX): Financial results for Q2 2026

RLX Technology Inc. (RLX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 RLX Technology Announces Unaudited Second Quarter 2026 Financial Results SHENZHEN, August 14, 2026 /PRNEWSWIRE/ - RLX Technology Inc. ("RLX Technology" or the "Company") (NYSE: RLX), a leading global branded e-vapor company, today announced its unaudited financial re

$RLXMedAI 8/10

Robust Earnings and International Expansion Assert RLX Technology Inc. (RLX) as a Top Sin Stock to Buy

RLX Technology (NYSE:RLX) reported first-quarter results on May 20 that beat expectations, driven by international expansion. Net revenues rose 96.2% to $229.9 million and gross margin improved to 31.8% from 28.6%. Adjusted net income increased 41.4% to $51.8 million, with adjusted EPS of $0.038. International operations were 72.3% of revenue, led by Europe and Asia.

$ARAYMed

Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter

Accuray (ARAY) reported a 21% revenue decline to $100.9M in Q4 2026, with China's market contributing to a 42% drop in product revenue. The company secured $60M in financing from TCW Asset Management, improving its balance sheet. Service revenue grew 6%, and cost savings exceeded targets. However, Accuray did not provide 2027 guidance due to trade policy uncertainties.

$BILLMedAI 8/10

Bill Holdings (BILL) Leans On AI To Power Its Next Chapter

Bill Holdings (BILL) reported Q4 revenue of $400.5M, up 16% YoY, with non-GAAP operating margin expanding 860 bps to 23%. AI adoption drove growth, with 175,000 businesses using AI agents. Non-GAAP net income rose 53% YoY to $94M. Management expects GAAP net profit above $125M in fiscal 2027. Growth slowed due to restructuring, with net-new customers at 1,800. Fiscal 2027 revenue growth guided to 11-14%, down from 16%.